TMHC:NYSETaylor Morrison Home Corporation Analysis

Taylor Morrison (TMHC) trades at $59.75, just above its 20‑day SMA of 60.83 and 50‑day SMA of 60.57, while the 200‑day SMA sits higher at 62.78, indicating a neutral technical stance. The RSI of 46.7 suggests neither overbought nor oversold conditions, but the MACD histogram is negative and the signal line is bearish, pointing to short‑term downside pressure. Volume has been decreasing, and the stock is hovering near the calculated support level of 57.35 with resistance around 66.80, framing a modest upside corridor. On the fundamentals side, TMHC shows a low trailing PE of 8.9, a price‑to‑book below 1 (0.92), and a DCF fair value of $53.12, implying the market may be pricing in a modest premium. Revenue fell sharply by 26.8% YoY, yet margins remain respectable (gross ~22.6%, operating ~11.1%) and cash generation is solid with $0.73 B free cash flow. Analysts collectively rate the stock as a Buy with a median target of $69, reflecting confidence in the company’s upcoming 11,000 closings and $400 M buyback plan. The Fear & Greed Index reads “Extreme Greed” at 90.66, hinting at bullish sentiment that may be overstretched given the 30‑day volatility of 38.7% and a beta near 0.92. Overall, the stock appears fairly valued with value‑oriented characteristics, but short‑term technical weakness and a volatile housing environment warrant caution.